We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

25 hedge funds and large institutions have $12M invested in VolitionRx Ltd in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

7% more capital invested

Capital invested by funds: $11.2M → $12M (+$765K)

0.12% more ownership

Funds ownership: 0.97% → 1.09% (+0.12%)

7% less funds holding

Funds holding: 27 → 25 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$1.56M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$41.4K
3
Squarepoint
Squarepoint
New York
+$36.2K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$18.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.8K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$164K
2
Citadel Advisors
Citadel Advisors
Florida
-$40.9K
3
Millennium Management
Millennium Management
New York
-$29.7K
4
TSS
Two Sigma Securities
New York
-$16.4K
5
UBS Group
UBS Group
Switzerland
-$14.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$5.81M +$1.56M +130,900 +35%
AC
2
Armistice Capital
New York
$4.68M -$164K -13,773 -3%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$434K +$10.8K +906 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$402K +$41.4K +3,470 +11%
BlackRock
5
BlackRock
New York
$254K – – –
State Street
6
State Street
Massachusetts
$84.2K – – –
SBCM
7
Silverberg Bernstein Capital Management
New York
$80.1K +$3.97K +333 +5%
Northern Trust
8
Northern Trust
Illinois
$67.2K – – –
UBS Group
9
UBS Group
Switzerland
$47.4K -$14.4K -1,208 -23%
Squarepoint
10
Squarepoint
New York
$34.7K +$36.2K +3,040 New
XT
11
XTX Topco
Cayman Islands
$18.4K +$6.51K +546 +51%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$17.4K +$18.2K +1,530 New
TSS
13
Two Sigma Securities
New York
$12.2K -$16.4K -1,372 -56%
CPIG
14
Chicago Partners Investment Group
Illinois
$9.2K +$10.6K +886 New
TRCT
15
Tower Research Capital (TRC)
New York
$7.22K +$2.43K +204 +48%
Millennium Management
16
Millennium Management
New York
$6.17K -$29.7K -2,491 -82%
Creative Planning
17
Creative Planning
Kansas
$5.73K -$7.84K -658 -57%
HFM
18
Hartford Financial Management
Connecticut
$2.85K – – –
FCMT
19
Founders Capital Management (Texas)
Texas
$1.14K – – –
Morgan Stanley
20
Morgan Stanley
New York
$513 -$5.96K -500 -92%
Bank of America
21
Bank of America
North Carolina
$353 +$24 +2 +7%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$171 +$179 +15 New
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$151 – – –
AF
24
Allworth Financial
California
$98 – – –
Citadel Advisors
25
Citadel Advisors
Florida
– -$40.9K -3,410 Closed
1
2

VNRX Hedge Fund Activity: Q1 2025 in Review

25 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2025, worth a combined $12M — up 6.8% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VNRX and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Lagoda Investment Management, adding an estimated $1.56M. The largest seller was Armistice Capital, cutting an estimated $164K.

  • 25 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2025, down from 27 in Q4 2024.
  • Funds reported $12M of VolitionRx Ltd stock for Q1 2025, up 6.8% quarter-over-quarter.
  • 4 funds opened new VolitionRx Ltd positions in Q1 2025 and 6 closed out, a net change of -2 holders.
  • The largest VolitionRx Ltd buyer in Q1 2025 was Lagoda Investment Management, an estimated $1.56M added.
  • The largest VolitionRx Ltd seller in Q1 2025 was Armistice Capital, an estimated $164K sold.

Based on aggregated 13F filings for Q1 2025.